UAE 3D Imaging Market Analysis Report 2022 to 2030

UAE 3D Imaging Market Analysis

$ 3999

The UAE 3D imaging market is projected to grow from $0.15 Bn in 2022 to $0.55 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. The market will be driven by expanding healthcare investments and rising demand for improved medical services. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare & Siemens Healthineers.

ID: IN10AEDH001 CATEGORY: Digital Health GEOGRAPHY: UAE AUTHOR: Vidhi Upadhyay

Buy Now

UAE 3D Imaging Market Executive Summary

The UAE 3D imaging market is projected to grow from $0.15 Bn in 2022 to $0.55 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. Current health expenditure per capita for UAE has raised from $2,843.78 in 2018 to $2,996.36 in 2019 as per the World Health Organization Global Health Expenditure database and it is expected to raise even more in the near future as the fundings raise by the government and private sectors. According to Globocan 2020, out of a total population of 98,90,400number of new cases of cancer in UAE was 4,807. 21.4% of which accounted for breast cancer, 10.6% for colorectal cancer, and 8.4% for thyroid cancer. CVD is the major cause of death in the UAE. Cardiovascular disease affects between 30 and 70% of the population & it has also been noted that 20% of adults smoke.

The UAE 3D imaging market is expanding, driven by rising demand for specialized diagnostic imaging technologies and the country's expanding healthcare sector. The UAE boasts an excellent healthcare infrastructure, with multiple world-class hospitals and clinics offering cutting-edge medical services such as 3D imaging. The UAE government has made major expenditures in the healthcare industry in recent years, including the use of modern medical technology such as 3D imaging. This has resulted in the rise of the country's 3D imaging industry and expanded patient access to high-end medical imaging services. Diagnostic imaging, interventional radiology, and surgery planning are some of the primary applications of 3D imaging in the UAE.

In February 2023, South Korean medical AI company Lunit announced a collaboration with Agfa HealthCare, a global imaging firm based in Belgium, to provide an AI image analysis solution for breast cancer diagnosis to the Dubai Academic Health Corporation (DAHC) in the UAE.

UAE 3D imaging market analysis

Market Dynamics

Market Growth Drivers

The UAE's healthcare sector is expanding, owing to rising demand for improved medical services and population expansion. The expansion of the healthcare industry is increasing the demand for improved medical technology. The UAE government has made major investments in the healthcare industry and created laws to encourage the use of modern medical technology such as 3D imaging. This has provided a favorable atmosphere for the expansion of the country's 3D imaging industry. The rising frequency of chronic illnesses such as cancer, cardiovascular disease, and diabetes is boosting demand for specialized diagnostic imaging technologies. Moreover, technological advancements and Increasing Demand for Minimally Invasive procedures are driving the demand for 3D imaging.

Market Restraints

The high cost of 3D imaging equipment and software is a key impediment to industry expansion. The cost of these technologies can be prohibitively expensive for many healthcare practitioners, especially those in the public sector, restricting the country's adoption of 3D imaging. Moreover, the limited availability of skilled personnel, such as radiologists and technologists, to operate and maintain 3D imaging, regulatory and reimbursement challenges & data privacy are some concerns to the growth of the market.

Competitive Landscape

Key Players

GE Healthcare
Philips Healthcare
Siemens Healthineers
Hitachi Medical Systems
Al Futtaim Technologies (ARE)
Bin Ali Medical Supplies (ARE)

Notable Deals

February 2023, GE HealthCare introduced a new, comprehensive Smart CT solution designed to help healthcare systems care for more patients with greater efficiency and clarity by increasing patient throughput by up to 50%, image quality by up to 30%, and daily prep by up to 85% due to improved efficiencies with higher workflow speed
In January 2022, Philips agreed to a memorandum of understanding (MoU) to cooperatively accelerate the essential, data-driven transformation of healthcare in the United Arab Emirates (UAE) in support of the Dubai Health Strategy 2021

Healthcare Policies and Regulatory Landscape

The Dubai Health Authority (DHA) and the Abu Dhabi Department of Health (DoH) are the regulating authorities for the 3D imaging sector in the UAE. These organizations are critical to assuring the quality and safety of medical imaging services and equipment in the UAE. In addition to their regulatory role, the DHA and DoH promote the growth and development of the UAE's 3D imaging sector. This involves funding R&D activities, encouraging the use of specialized diagnostic imaging technology in healthcare, and collaborating with key stakeholders to develop new and creative medical imaging solutions.

Reimbursement Scenario

The Ministry of Health and Prevention (MOHAP) governs medical service reimbursement, including 3D imaging. MOHAP maintains a list of authorized medical services and procedures, including 3D imaging, and establishes reimbursement levels for each treatment. Individual insurance companies determine reimbursement rules for people with private health insurance, which might differ between firms. Depending on the conditions of their insurance coverage, individuals with both public and private health insurance may be asked to pay a percentage of the cost of the 3D imaging process, such as a co-pay or deductible.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UAE 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.